Search results for "VIROLOGY"

showing 10 items of 2354 documents

On the hemagglutinating and hemolytic activity of measles virus variants.

1967

The hemagglutinating (HA) and hemolytic (HL) activity of two measles virus variants, differing with regard to type of CPE and other characteristics, have been investigated.

medicine.medical_specialtybiologyvirusesHemagglutinationGenetic VariationGeneral Medicinebiochemical phenomena metabolism and nutritionbiology.organism_classificationVirologyHemolysisMeasles virusMedical microbiologyCytopathogenic Effect ViralCell cultureInfectious disease (medical specialty)Giant cellMeasles virusVirologymedicineHeLa CellsArchiv fur die gesamte Virusforschung
researchProduct

Hepatitis C virus resistance to new specifically-targeted antiviral therapy: A public health perspective

2012

Until very recently, treatment for chronic hepatitis C virus (HCV) infection has been based on the combination of two non-viral specific drugs: pegylated interferon-α and ribavirin, which is effective in, overall, about 40%-50% of cases. To improve the response to treatment, novel drugs have been designed to specifically block viral proteins. Multiple compounds are under development, and the approval for clinical use of the first of such direct-acting antivirals in 2011 (Telaprevir and Boceprevir), represents a milestone in HCV treatment. HCV therapeutics is entering a new expanding era, and a highly-effective cure is envisioned for the first time since the discovery of the virus in 1989. H…

medicine.medical_specialtybusiness.industryPublic healthHepatitis C virusRibavirinAntiviral therapymedicine.disease_causeVirologyResponse to treatmentVirusTelaprevirchemistry.chemical_compoundchemistryBoceprevirmedicineMinireviewbusinessmedicine.drugWorld Journal of Virology
researchProduct

Boceprevir in the treatment of chronic hepatitis C virus infection

2011

1Hepatology-Liver Transplantation Unit, Digestive Medicine Service, Hospital Universitari La Fe, and National Network Center for Hepatology and Gastroenterology Research, instituto de Salud Carlos iii, CiBeReHD Spain; 2CSiSP, Center for Public Health Research, Public Health Department, Generalitat Valenciana and Microbioloy Department/ institut Cavanilles, University of Valencia, Valencia, Spain; 3National Network Center for Biomedical Research in epidemiology and Public Health, instituto de Salud Carlos iii, CiBeReSP Spain

medicine.medical_specialtybusiness.industryPublic healthImmunologyTransplantationchemistry.chemical_compoundInfectious DiseaseschemistryChronic hepatitisVirologyFamily medicineBoceprevirEpidemiologymedicinebusinessVirus Adaptation and Treatment
researchProduct

The relevance for Public Health of the mid-term and interim analyses of seasonal influenza vaccination effectiveness

2019

Worldwide, influenza is commonly recognized as a respiratory virus that causes a high number of deaths every year, especially among elderly adults and people with chronic illnesses. In order to reduce morbidity and mortality, many countries have implemented, in the last decades, universal influenza vaccination programs with special attention on groups at increased risk of developing the disease, such as pregnant women, children aged 6–59 months, elderly adults and individuals with specific chronic medical conditions. In real-world conditions, observational (nonrandomized) studies on vaccine effectiveness (VE) could measure,the risk reduction of contracting a disease and are considered the g…

medicine.medical_specialtybusiness.industryPublic healthsurveillance networktest-negative designinfluenza vaccine effectiveneSettore MED/42 - Igiene Generale E ApplicataTerm (time)VaccinationSeasonal influenzaVirologyEnvironmental healthInterimmedicineinfluenza viruseRelevance (information retrieval)influenza epidemicbusinesslaboratory confirmed case
researchProduct

Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve …

2011

Summary.  In chronic hepatitis C (CHC), treatment duration may be individualized according to time to first undetectable hepatitis C virus (HCV) RNA, with patients who attain undetectable HCV RNA early in treatment being candidates for shorter regimens. The aim of this study was to determine the relapse rate in patients with CHC genotype (G) 1 infection and low baseline viral load who achieved undetectable HCV RNA by week 4 [rapid virologic response (RVR)] when treated for 24 weeks. This was an open-label, multicentre, noninterventional study. Adult patients with G1 CHC infection and baseline viral load <600,000 IU/mL who attained RVR were treated with peginterferon alfa-2b (1.5 μg/kg/week)…

medicine.medical_specialtyeducation.field_of_studyHepatologybusiness.industryRibavirinHepatitis C virusPopulationvirus diseasesmedicine.disease_causeGastroenterologychemistry.chemical_compoundInfectious DiseaseschemistryVirologyInternal medicineImmunologymedicineClinical endpointPeginterferon alfa-2bRapid Virologic ResponseeducationbusinessAdverse effectViral loadmedicine.drugJournal of Viral Hepatitis
researchProduct

O071 : Telomerase reverse transcriptase mutations are associated with hepatocellular carcinoma in nash

2015

O071 TELOMERASE REVERSE TRANSCRIPTASE MUTATIONS ARE ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN NASH B. Donati, E. Vanni, P. Dongiovanni, M. Iavarone, R. Rametta, C. Rosso, A. Carnelutti, S. Petta, A.L. Fracanzani, H.L. Reeves, J.F. Dofour, L. Miele, Q. Anstee, E. Bugianesi, G. Soardo, S. Fargion, L. Valenti. Pathophysiology and Transplantation, Universita degli Studi di Milano, Milano, Medical Sciences, University of Turin, Turin, Internal Medicine, Gastroenterology, Fondazione IRCCS Ca’ Granda, Milano, Internal Medicine, University of Udine, Udine, Gastroenterology, University of Palermo, Palermo, Italy; Medicine, Freeman Hospital, Newcastle Upon Tyne, United Kingdom; Clinical Research, U…

medicine.medical_specialtyfood.ingredientHepatologybusiness.industryGeneral surgerymedicine.diseaseVirologyTransplantationfoodNewcastle upon tyneHepatocellular carcinomamedicinePettaTelomerase reverse transcriptasebusinessJournal of Hepatology
researchProduct

Determinants of high-grade anal intraepithelial lesions in HIV-positive men having sex with men

2018

Background Identifying determinants for histologically proven high-grade anal intraepithelial lesions (hHSIL) in HIV-positive MSM would allow better targeted screening. Methods APACHES is a prospective study of anal HPV and related-lesions in 513 HIV-positive MSM aged ≥35 in six clinics across France. At baseline, participants underwent high resolution anoscopy (HRA) with biopsy of suspicious lesions, preceded by anal swabs for liquid-based cytology, p16/Ki67 immunostaining, and HPV DNA. hHSIL diagnosis was established by histopathological review panel consensus, and determinants assessed by logistic regression. Results Baseline hHSIL prevalence was 10.4% and did not differ significantly by…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryHuman immunodeficiency virus (HIV)medicine.diseasemedicine.disease_causeLogistic regressionlcsh:Infectious and parasitic diseasesLesionInfectious DiseasesVirologyInternal medicineCytologyBiopsymedicinelcsh:RC109-216medicine.symptomProspective cohort studybusinessAscusImmunodeficiencyPapillomavirus Research
researchProduct

Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant.

2004

Background Highly publicised outbreaks of norovirus gastroenteritis in hospitals in the UK and Ireland and cruise ships in the USA sparked speculation about whether this reported activity was unusual. Methods We analysed data collected through a collaborative research and surveillance network of viral gastroenteritis in ten European countries (England and Wales were analysed as one region). We compiled data on total number of outbreaks by month, and compared genetic sequences from the isolated viruses. Data were compared with historic data from a systematic retrospective review of surveillance systems and with a central database of viral sequences. Findings Three regions (England and Wales,…

medicine.medical_specialtyvirusesmedicine.disease_causeDisease Outbreaks03 medical and health sciencesEpidemiologyEpidemic spreadmedicineHumans030304 developmental biologyCaliciviridae InfectionsRetrospective Studies0303 health sciencesInternational network030306 microbiologybusiness.industryNorovirusGenetic variantsOutbreakGenetic VariationGeneral MedicineNew variantVirology3. Good healthGastroenteritisEuropePopulation SurveillanceMutationNorovirusFood MicrobiologyViral diseaseSeasonsbusinessLancet (London, England)
researchProduct

Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time…

2010

5 páginas, 3 figuras.

medicine.medical_treatmentCongenital cytomegalovirus infectionCytomegalovirusHematopoietic stem cell transplantationHematopoietic stem cell transplantationBiologyPolymerase Chain ReactionAutomationPlasmaVirologymedicineHumansViral loadHematopoietic Stem Cell Transplantationvirus diseasesViral LoadUniversity hospitalmedicine.diseaseVirologyDNA extractionAllogeneic stem cell transplantReverse transcription polymerase chain reactionInfectious DiseasesReal-time polymerase chain reactionSpainImmunologyCytomegalovirus InfectionsAllogeneic hematopoietic stem cell transplantViral loadReal-time PCRJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology
researchProduct

Induction of Type-Specific Neutralizing Antibodies by Capsomeres of Human Papillomavirus Type 33

2001

Abstract The immunogenicity of capsomeres of human papillomavirus type 33 was evaluated in a dose–response analysis. Capsomeres were obtained free of capsids by expression of L1 carrying the single point mutation C427S. Neutralizing antibodies were detected using an in vitro pseudoinfection assay. Capsomeres induced type-specific, neutralizing antibodies in mice even in the absence of adjuvant. The neutralization titers of immune sera raised without adjuvant were 10- to 20-fold lower than those of antisera to virus-like particles, but virtually identical using Freund's adjuvant. These data indicate that capsomeres may substitute for virus-like particles in future vaccines when used with an …

medicine.medical_treatmentDose-Response Relationship ImmunologicEnzyme-Linked Immunosorbent AssayAntibodies ViralpapillomavirusNeutralizationMiceCapsidNeutralization Testsdose responseVirologymedicineAnimalsHumansPapillomaviridaeAntiserumMice Inbred BALB CbiologyImmunogenicityCapsomereVirionneutralizationvaccinationVirologyTiterCapsidbiology.proteincapsomeresImmunizationAntibodyAdjuvantVirology
researchProduct